9）Reponen EJ, Tesli M, Dieset I, Steen NE, Vedal TSJ, Szabo A, et al. Adiponectin is related to cardiovascular risk in severe mental illness independent of antipsychotic treatment. Front Psychiatry 2021; 12: 623192.10）Mednova IA, Boiko AS, Kornetova EG, Parshukova DA, Semke AV, Bokhan NA, et al. Adipocytokines and Metabolic Syndrome in Patients with Schizophrenia. Metabolites 2020; 10: 410.11）Tay YH, Lee J. The relationship between serum adiponectin levels, cardiometabolic indices and metabolic syndrome in schizophrenia. Asian J Psychiatr 2019; 43: 1-6.12）Sapra M, Lawson D, Iranmanesh A, VarmaA. Adiposity-independent hypoadiponectinemia as a potential marker of insulin resistance and inflammation in schizophrenia patients treated with second generation antipsychotics. Schizophr Res 2016; 174: 132-6.13）Hanssens L, van Winke lR, Wampers M, Van Eyck D, Scheen A, Reginster JY, et al. A cross-sectional evaluation of adiponectin plasma levels in patients with schizophrenia and schizoaffective disorder. Schizophr Res 2008; 106: 308-14.14）Toda M, Tsukinoki R, Morimoto K. Measurement of salivary adiponectin levels. Acta Diabetol 2007; 44(1): 20-2.374: 635-45. 文 献144 1）vanOs J, Kapur S. Schizophrenia. Lancet 2009; 2）Kredentser MS, Martens PJ, Chochinov HM, PriorHJ. Cause and rate of death in people with schizophrenia across the lifespan: a population-based study in Manitoba, Canada. J Clin Psychiatry 2014; 75: 154-61. 3）Leucht S, Cipriani A, Spineli L, Mavridis D, Orey D, Richter F, et al. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. Lancet 2013; 382: 951-62. 4）Muench J, Hamer AM. Adverse effects of antipsychotic medications. Am Fam Physician 2010; 81: 617-22. 5）Weinmann S, Read J, Aderhold V. Influence of antipsychotics on mortality in schizophrenia: systematic review. Schizophr Res 2009; 113: 1-11. 6）Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004; 89: 2548-56. 7）Miwa R, Nakamura T, Kihara S, Kumada M, Shibazaki S, Takahashi M, et al. Adiponectin as a biomarker of the metabolic syndrome. Circ J 2004; 68: 975-81. 8）Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999; 257: 79-83.
元のページ ../index.html#162